Specialist Investor
Differentiated approach
Enabling world-class leadership teams to succeed on the global stage
Global Healthcare Opportunities
Better, faster + more accessible healthcare
Embedded
in healthcare
Updates
- Velocity Clinical Research growth skyrockets with eight site acquisitionsAcquisition of MedPharmics gives Velocity access to African American and Native American patient populations. London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company Velocity Clinical, regarding the acquisition of MedPharmics.Velocity Clinical Research (“Velocity”), the leading…
- RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMOCombination creates global leader in process development and GMP manufacturing of advanced cell and gene therapies with transatlantic footprint in the US and UK Key leadership, staff and shareholders of both businesses will remain and have reinvested in the new entity, with a shared strategic vision for growth London, UK…
- Velocity Clinical Research begins European expansion with German site acquisitionLondon, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company Velocity Clinical Research, regarding the acquisition of Clinical Research Hamburg, Germany. Velocity Clinical Research (“Velocity”), the leading integrated research site organisation, today announced that it has acquired its first…
